50 Facts About Bayer


Bayer AG is a German multinational pharmaceutical and biotechnology company and one of the largest pharmaceutical companies in the world.

FactSnippet No. 1,006,886

Bayer is a component of the Euro Stoxx 50 stock market index.

FactSnippet No. 1,006,887

Bayer was founded in 1863 in Barmen as a partnership between dye salesman Friedrich Bayer and dyer Friedrich Weskott.

FactSnippet No. 1,006,888

The versatility of aniline chemistry led Bayer to expand their business into other areas, and in 1899 Bayer launched the compound acetylsalicylic acid under the trademarked name Aspirin.

FactSnippet No. 1,006,889

In 1925 Bayer merged with five other German companies to form IG Farben, creating the world's largest chemical and pharmaceutical company.

FactSnippet No. 1,006,890

Bayer played a key role in the Wirtschaftswunder in post-war West Germany, quickly regaining its position as one of the world's largest chemical and pharmaceutical corporations.

FactSnippet No. 1,006,891

Bayer AG was founded as a dyestuffs factory in 1863 in Barmen, Germany, by Friedrich Bayer and his partner, Johann Friedrich Weskott, a master dyer.

FactSnippet No. 1,006,892

Friedrich Bayer, son of the company's founder, was a chemist and joined the company in 1873.

FactSnippet No. 1,006,893

Arthur Eichengrun, a Bayer chemist, said he was the first to discover an aspirin formulation that did not have the unpleasant side effects of nausea and gastric pain.

FactSnippet No. 1,006,894

Bayer said he had invented the name aspirin and was the first person to use the new formulation to test its safety and efficacy.

FactSnippet No. 1,006,895

Bayer contends that aspirin was discovered by Felix Hoffmann to help his father, who had arthritis.

FactSnippet No. 1,006,896

Bayer scientists were not the first to make heroin, but the company led the way in commercializing it.

FactSnippet No. 1,006,897

In 1903, Bayer licensed the patent for the hypnotic drug diethylbarbituric acid from its inventors Emil Fischer and Joseph von Mering.

FactSnippet No. 1,006,898

Systematic investigations of the effect of structural changes on potency and duration of action at Bayer led to the discovery of phenobarbital in 1911 and the discovery of its potent anti-epileptic activity in 1912.

FactSnippet No. 1,006,899

In 1916, Bayer scientists discovered suramin, an anti-parasite drug that is still sold by Bayer under the brand name Germanin.

FactSnippet No. 1,006,900

In 1925, Bayer became part of IG Farben, a German conglomerate formed from the merger of six chemical companies: BASF, Bayer, Hoechst, Agfa, Chemische Fabrik Griesheim-Elektron, and Chemische Fabrik vorm.

FactSnippet No. 1,006,901

Bayer was forced by the Nazi Party to relinquish the reward; German citizens had been forbidden from accepting Nobel prizes since the Nobel committee had awarded the 1935 Nobel Peace Prize to a German pacifist, Carl von Ossietzky.

FactSnippet No. 1,006,902

Bayer was elected to Bayer AG's supervisory board in 1956, a position he retained until 1964.

FactSnippet No. 1,006,903

In 1953, Bayer brought the first neuroleptic onto the German market.

FactSnippet No. 1,006,904

In 1978, Bayer purchased Miles Laboratories and its subsidiaries Miles Canada and Cutter Laboratories, acquiring along with them a variety of product lines including Alka-Seltzer, Flintstones vitamins and One-A-Day vitamins, and Cutter insect repellent.

FactSnippet No. 1,006,905

Companies, including Bayer, developed new ways to treat donated blood with heat to decontaminate it, and these new products were introduced early in 1984.

FactSnippet No. 1,006,906

Bayer said it did this because some countries were doubtful about the efficacy of the new product.

FactSnippet No. 1,006,907

Bayer has been involved in other controversies regarding its drug products.

FactSnippet No. 1,006,908

Bayer produces various fungicides, herbicides, insecticides, and some crop varieties.

FactSnippet No. 1,006,909

In 2004, Bayer HealthCare acquired the over-the-counter pharmaceutical division of Roche.

FactSnippet No. 1,006,910

In March 2008, Bayer HealthCare announced an agreement to acquire the portfolio and OTC division of privately owned Sagmel, Inc, a US-based company that markets OTC medications in most of the Commonwealth of Independent States countries such as Russia, Ukraine, Kazakhstan, Belarus, and others.

FactSnippet No. 1,006,911

In November 2010, Bayer AG signed an agreement to buy Auckland-based animal health company Bomac Group.

FactSnippet No. 1,006,912

In 2014, Bayer agreed to buy Merck's consumer health business for $14.

FactSnippet No. 1,006,913

In June 2015, Bayer agreed to sell its diabetic care business to Panasonic Healthcare Holdings for a fee of $1.

FactSnippet No. 1,006,914

Effective January 2016 following the spinout of Covestro, Bayer rebranded itself as a life sciences company, and restructured into three divisions and one business unit: Pharmaceuticals, Consumer Health, Crop Science, and Animal Health.

FactSnippet No. 1,006,915

In May 2016, Bayer offered to buy U S seeds company Monsanto for $62 billion.

FactSnippet No. 1,006,916

Shortly after Bayer's offer, Monsanto rejected the acquisition bid, seeking a higher price.

FactSnippet No. 1,006,917

Also in 2002, Bayer AG acquired the Dutch seed company Nunhems, which at the time was one of the world's top five seed companies.

FactSnippet No. 1,006,918

On 1 July 2011, Bayer CropScience agreed to a global settlement for up to $750 million.

FactSnippet No. 1,006,919

In 2016, as part of the wholesale corporate restructuring, Bayer CropScience became one of the three major divisions of Bayer AG, reporting directly to the head of the division, Liam Condon.

FactSnippet No. 1,006,920

The global headquarters of Bayer CropScience is located in St Louis, Missouri, United States.

FactSnippet No. 1,006,921

Bayer BioScience, headquartered in Hyderabad, India, has about 400 employees, and has research, production, and an extensive sales network spread across India.

FactSnippet No. 1,006,922

Bayer Pharma produces the birth control pills Yaz and Yasmin.

FactSnippet No. 1,006,923

Bayer MaterialScience was a supplier of high-tech polymers, and developed solutions for a broad range of applications relevant to everyday life.

FactSnippet No. 1,006,924

On 18 September 2014, the Board of Directors of Bayer AG announced plans to float the Bayer MaterialScience business on the stock market as a separate entity.

FactSnippet No. 1,006,925

On 1 June 2015, Bayer announced that the new company would be named Covestro; Bayer formally spun out Covestro in September 2015.

FactSnippet No. 1,006,926

Bayer's shares traded at over €69 per share, and its market capitalization was valued at US€65.

FactSnippet No. 1,006,927

In September 2019, Bayer announced to reduce the number of management board members from seven to five to reduce overall costs.

FactSnippet No. 1,006,928

Bayer USA was given a score of 85 in the Human Rights Campaign's 2011 Corporate Equality Index, a measure of gay and lesbian workplace equality.

FactSnippet No. 1,006,929

Bayer received an EE- rating, the fourth tier in an eight-tier ranking.

FactSnippet No. 1,006,930

Jury found that the plaintiffs failed to prove that Bayer misrepresented its One A Day claims, and did not demonstrate that any of the class representative consumers who purchased One A Day relied on the so-called false information as part of their buying decision.

FactSnippet No. 1,006,931

Bayer misrepresented the results of its own research and knowingly supplied hemophilia medication tainted with HIV to patients in Asia and Latin America, without the precaution of heat treating the product, recommended for eliminating the risk.

FactSnippet No. 1,006,932

On 15 February 2020, Bayer-representing Monsanto- and BASF were ordered to pay not only the $15 million in damages, but an additional $250 million in punitive damages.

FactSnippet No. 1,006,933

In June 2020, Bayer agreed to pay $800 million to settle lawsuits in a variety of jurisdictions which claimed contamination of public waterways with PCBs by Monsanto before 1978.

FactSnippet No. 1,006,934

On 25 November 2020 U S District Judge Fernando M Olguin rejected Bayer's settlement offer, which was now at $650 million, and allowed Monsanto-related lawsuits involving PCB to proceed.

FactSnippet No. 1,006,935